Kari Krogstad • 1964 • Skedsmokorset • 7 roles • 4 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
K K2 CONSULTING AS	Managing Director/CEO	-	3,500,279	100 % directly
M MEDISTIM ASA	Managing Director/CEO	442,562,000	-	-

Boards

Name	Role	Total operating income	Total equity	Shares
K K2 CONSULTING AS	Chairman	-	3,500,279	100 % directly
E ENGELIA INVEST AS	Alternate Member	5,880	8,526,176	-
M MEDISTIM NORGE AS	Chairman	101,057,000	21,079,000	-
V VISTIN PHARMA ASA	Board Member	-	184,035,000	-
N NEURO BIDCO AS	Board Member	-	186,054,167	-

Last update: Nov 6, 2025

Related industries3

Direct relationships5

TK
Tore Krogstad1967
ENGELIA INVEST AS, K2 CONSULTING AS
ØA
Øyvin Anders Brøymer1948
MEDISTIM ASA, VISTIN PHARMA ASA
TR
Tove Raanes1977
MEDISTIM ASA
KJ
Kai Jordahl1960
NEURO BIDCO AS
EW
Espen Weyergang Marcussen1968
VISTIN PHARMA ASA

Shares owned by Kari Eian Krogstad

Name	Share class	Total operating income	Total equity	Share
K K2 CONSULTING AS	Ordinære aksjer	0	3,500,279	100 % directly
A AUGERE MEDICAL AS Under liquidation	Ordinære aksjer	1,159,800	27,660,381	0.45 % directly < 0.01 %
M MEDISTIM ASA	NO0010159684	442,562,000	0	0.26 % directly < 0.01 %
G GENTIAN DIAGNOSTICS ASA	NO0010748866	2,245,000	241,156,128	0.02 % directly < 0.01 %

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025